DiphtheriaTetanus-Acellular Pertussis Vaccine
Overview
.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
DiphtheriaTetanus-Acellular Pertussis Vaccine is contraindicated in conditions like Hypersensitivity.
Back to top
Back to top
Side Effects
Back to top
Dosage
DiphtheriaTetanus-Acellular Pertussis Vaccine's dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
No data regarding the Adult dosage details of DiphtheriaTetanus-Acellular Pertussis Vaccine is available. |
Paedriatic Dosage (20kg)
|
No data regarding the Paedriatic dosage details of DiphtheriaTetanus-Acellular Pertussis Vaccine is available. |
Neonatal Dosage (3kg)
|
No data regarding the neonatal dosage details of DiphtheriaTetanus-Acellular Pertussis Vaccine is available. |
High Risk Groups
Back to top
Warning / Precautions
Administration of the vaccine should be postpond in subjects suffering from acute severe febrile ilness. If any of the following events occur in temporal relation to receipt of DTPa and DTPw , the decision to give subsequent doses of vaccine containing the pertussis component should be carefully considered: temperature of 40.5°C within 48 hrs of vaccination, not due to another identifiable cause; collapse or shock like state (hypnotic or hyporesponsive episode) within 48 hrs of vaccination; persistent inconsolable crying lasting 3 hrs occuring within 48 hrs of vaccination, convulsions with or without fever occuring with in three days of vaccination. Vaccine under no circumtances be administered intravenously.
Back to top
Back to top
Interference in Pathology
No data regarding the pathological interferences produced by DiphtheriaTetanus-Acellular Pertussis Vaccine is available.
Back to top
Brands / Trade Names of
DiphtheriaTetanus-Acellular Pertussis Vaccine
Back to top
Manufacturers of
DiphtheriaTetanus-Acellular Pertussis Vaccine
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic